These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15254410)

  • 1. 2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines.
    Dwarakanath BS; Khaitan D; Ravindranath T
    Cancer Biol Ther; 2004 Sep; 3(9):864-70. PubMed ID: 15254410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.
    Gupta S; Mathur R; Dwarakanath BS
    Cancer Biol Ther; 2005 Jan; 4(1):87-94. PubMed ID: 15711125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
    Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS; Adhikari JS; Jain V
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
    Varshney R; Dwarakanath B; Jain V
    Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of topoisomerases in cytotoxicity induced by DNA ligand Hoechst-33342 and UV-C in a glioma cell line.
    Singh S; Dwarakanath BS; Lazar Mathew T
    Indian J Exp Biol; 2005 Apr; 43(4):313-23. PubMed ID: 15875714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cells.
    Kim JS; Amorino GP; Pyo H; Cao Q; Choy H
    Radiother Oncol; 2002 Jan; 62(1):61-7. PubMed ID: 11830313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of radionuclide induced cytotoxicity by 2-deoxy-D-glucose in human tumor cell lines.
    Shrivastava V; Mishra AK; Dwarakanath BS; Ravindranath T
    J Cancer Res Ther; 2006; 2(2):57-64. PubMed ID: 17998676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the radiosensitizing effects of the DNA ligand hoechst-33342 in human tumor cell lines.
    Adhikari JS; Khaitan D; Arya MB; Dwarakanath BS
    J Cancer Res Ther; 2005; 1(3):151-61. PubMed ID: 17998647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line.
    Khaitan D; Chandna S; Arya MB; Dwarakanath BS
    Cancer Biol Ther; 2006 Sep; 5(9):1142-51. PubMed ID: 16855378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
    Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
    DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
    Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of resistance to etoposide and adriamycin in a human glioma cell line treated with antisense oligodeoxynucleotide complementary to the messenger ribonucleic acid of deoxyribonucleic acid topoisomerase II alpha.
    Kuriyama M; Tsutsui K; Tsutsui K; Ono Y; Tamiya T; Matsumoto K; Furuta T; Ohmoto T
    Neurol Med Chir (Tokyo); 1997 Sep; 37(9):655-61; discussion 661-2. PubMed ID: 9330528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
    Kusumoto H; Rodgers QE; Boege F; Raimondi SC; Beck WT
    Cancer Res; 1996 Jun; 56(11):2573-83. PubMed ID: 8653700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
    Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
    Kalia VK; Devi NK
    Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
    Kalia VK; Prabhakara S; Narayanan V
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines.
    Ng CE; Bussey AM; Raaphorst GP
    Int J Radiat Biol; 1994 Jul; 66(1):49-57. PubMed ID: 8027612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.